FDA offers more clarity on safety testing for cell therapies
The FDA is providing sponsors of cell therapies with a new draft guidance document on the kinds of safety testing they should perform.
The 14 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
